CLASS I Drug recall · Reported 20 Jun 2018 · FDA Enforcement Report

Taytulla Softgel Capsules, 1 mg/20 mcg recalled by Allergan, PLC

Allergan is recalling Taytulla Softgel Capsules, 1 mg/20 mcg, blister card Physicians's Sample - Not for Sale, distributed nationwide in the US. The recall was initiated on 24 May 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot# 5620706, Exp. 05/19
NDC0023-5862
UPC300235862290
Quantity recalled168,768 blister cards (4,725,504 softgel capsules)

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0875-2018
FDA event ID
80136
Recalling firm
Allergan, Madison, NJ
Manufacturer
Allergan, Inc.
Classification
Class I
Status
Terminated
Recall initiated
24 May 2018
FDA classified
15 Jun 2018
Reported
20 Jun 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

24 May 2018Recall initiated by company
15 Jun 2018Classified by FDA+22 days
20 Jun 2018Published in enforcement report+5 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Contraceptive Tablets Out of Sequence.

Product as listed by the FDA

Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290

Where it was distributed

US Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Contraceptive Tablets Out of Sequence.

Which lots are affected?

Lot# 5620706, Exp. 05/19

Where was it sold?

US Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Allergan

All 29

Other Norethindrone recalls

All 8